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p53 Protein Exhibits 39-to-59 Exonuclease Activity
Torsten Mummenbrauer,* Friedemann Janus,* age-induced p53 functions, evidence for a direct in-
volvement of p53 in cellular DNA replication and DNABeate Mu¨ller,* Lisa Wiesmu¨ller,* Wolfgang Deppert,*
and Frank Grosse† repair has accumulated (reviewed in Deppert, 1994).
Such an involvement can be deduced from several find-*Heinrich-Pette-Institut fu¨r Experimentelle Virologie
und Immunologie ings: that p53 colocalizes with PCNA, DNA polymerase
a, DNA ligase, and RPA at discrete regions in the nucleiMartinistr. 52
D-20251 Hamburg of Herpes virus–infected cells (Wilcock and Lane, 1991);
that p53 exerts direct effects on nuclear DNA replicationGermany
†Institut fu¨r Molekulare Biotechnologie (Cox et al., 1995); that p53 binds to the replication factor
RPA (Dutta et al., 1993; Li and Botchan, 1993); and thatAbteilung Biochemie
Beutenbergstr. 11 p53 expression in cells, stimulated to reenter prolifera-
tion, closely follows the pattern of cellular DNAsynthesisD-07745 Jena
Germany (Mosner and Deppert, 1994; Mosner et al., 1995). Since
p53 is not absolutely required for cellular proliferation
(see above), one has to assume an auxiliary rather than
a mandatory function of p53 in proliferation.Summary
In addition to its functions as transactivator and re-
pressor, several other biochemical activities have beenHighly purified p53 protein from different sources was
ascribed to the p53 protein. In agreement with its roleable to degrade DNA with a 39-to-59 polarity, yielding
as a transactivator, p53 has been shown to bind DNAdeoxynucleoside monophosphates as reaction prod-
in a sequence-specific manner (Bargonetti et al., 1991;ucts. Thisexonuclease activity was dependent on Mg21
Kern et al., 1991b; Funk et al. 1992; Zambetti et al., 1992;and inhibited by addition of 5 mM nucleoside mono-
Miyashita and Reed, 1995) and to comprise a peptidephosphates. This exonuclease activity is intrinsic to
domain mediating transactivation from a promotorthe wild-type p53 protein: it copurified with p53 during
downstream of the p53 DNA binding motif (El-Deiry etp53 preparation; only purified wild-type p53, but not
al., 1992; Kern et al., 1992; Scha¨rer and Iggo, 1992). Inidentically purified mutant p53 proteins displayed exo-
addition to sequence-specific DNA binding, p53 proteinnuclease activity; the exonuclease activity could be
binds nonspecifically to double-stranded (ds) and sin-reconstituted from SDS gel-purified and urea-rena-
gle-stranded (ss) DNA (Steinmeyer and Deppert, 1988;tured p53 protein and mapped to the core domain of
Kern et al., 1991a). Furthermore, it has been describedthe p53 molecule; and finally, purified p53 protein
to reanneal both RNA and DNA (Oberosler et al., 1993;could be UV cross-linked to GMP. A p53-intrinsic exo-
Bakalkin et al., 1994; Brain and Jenkins, 1994). The latternuclease activity should substantially extend our view
two functions might be important in processes associ-on the role of p53 as a “guardian of the genome.”
ated with DNA repair, like recognition of DNA damage
(Lee et al., 1995) and prevention of unscheduled recom-Introduction
bination, as well as in regulation of DNA replication,
which could explain its apparent colocalization with rep-Mutations in the gene of the cellular protein p53 are
licative complexes. Hence, DNA binding, particularly tofound in >50% of all human tumors, suggesting that
single-strand/double-strand junctions, the DNA strandloss of this gene represents an important step in the
transfer, and the DNA strand annealing activity (Ober-formation of human cancers (Hollstein et al., 1991; Vo-
osler et al., 1993; Bakalkin et al., 1994; Brain and Jenkins,gelstein and Kinzler, 1992; Harris and Hollstein, 1993).
1994) might point to an additional role of p53 in pro-Despite its central role in the process of carcinogenesis,
cesses different from that in transcriptional regulation.the gene is dispensable, because p53 double-null mice
To get access to such a postulated function, we charac-develop normally; they exhibit, however, a dramatic inci-
terized the interactions of p53 with DNA. Thereby, wedence of tumors in adulthood (Donehower et al., 1992;
found that a Mg21-dependent exonuclease activity isHarvey et al., 1993). p53 protein has been shown to
intrinsically associated with the p53 protein. Possibleact as a cell cycle regulator that, when overexpressed,
physiological functions of this activity in the process ofprevents the transition from G1 to S phase of the cell
tumor prevention are discussed.cycle (Mercer et al., 1990; Lin et al., 1992). This action
of p53 has been ascribed to its ability to induce expres-
Resultssion of genes involved in growth arrest, like the waf1/
cip1 gene that encodes a 21 kDa inhibitor of G1 cyclin-
Highly Purified p53 Protein Displaysdependent protein kinases (El-Deiry et al., 1993; Harper
Exonuclease Activityet al., 1993). An intracellular increase of p53 protein has
We have purified wild-type (wt) p53 protein to near ho-been reported as result of various genotoxic treatments
mogeneity from four different sources: Sf9 insect cells(Kuerbitz et al., 1992; Fritsche et al., 1993; Hartwell and
Kastan, 1994), which in turn induces DNA repair or infected with a mouse wt p53-recombinant baculovirus,
clone 6 rat cells that ectopically express a temperature-apoptosis (reviewed in Marx, 1993; Cox and Lane, 1995).
This led to the concept of the “guardian of the genome” sensitive mouse p53 protein (Michalovitz et al., 1990),
Escherichia coli bacteria that overexpressa soluble formfor p53 (Lane, 1992). However, in addition to the dam-
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of human wt p53 protein, and bacteria that produce an
insoluble form of mouse wt p53 protein. The baculovi-
rus-produced protein was purified by nickel-chelate af-
finity chromatography or by affinity chromatography
using the immobilized monoclonal antibody PAb421,
elution with 1 M KCl, and subsequent elution at pH 12.
Alternatively, p53-containing fractions eluted from the
PAb421 antibody column were pooled and further puri-
fied by column chromatography on heparin-sepharose.
The soluble bacterial protein was also purified by
PAb421 affinity chromatography and elution with 1 M
KCl (pH 12), or by conventional column chromatography
according to the method of Hupp et al. (1992). The puri-
fied proteins were tested for sequence-specific and un-
specific ss- or dsDNA binding under a variety of different
assay conditions. Here we observed that, whenever
Mg21 had been added to the assay mixture, a substantial
part of the DNA substrate became degraded. DNA deg-
radation was dependent on both the time of incubation
(Figure 1, lanes 1–3 and 5–10) and the concentration of
added p53 protein (see Figures 2 and 5).
Figure 2 and Table 1 demonstrate the copurification
of p53 protein and of exonuclease activity from lysates
of Sf9 insect cells infected with a mouse wt p53-recom-
binant baculovirus. Due to the presence of a large
amount of not-p53 related exonuclease activity in the
lysate (see Table 1), demonstration of the exonuclease
activity specifically associated with p53 required sub-
stantial prepurification of p53. This was achieved by
immunoaffinity chromatography, where the crude lysate
was applied to a PAb421 antibody column, and p53 was
eluted with high salt (1 M KCl). Aliquots of each fraction
were subjected to SDS–polyacrylamide gel electropho-
resis (SDS–PAGE), followed by silver staining (Figure
2A), and analyzed in parallel for exonuclease activity
(Figure 2B) by the filter retention assay as described in
Experimental Procedures. The identity of the protein
migrating at 53 kDa in Figure 2A with p53 was verified
by Western blotting (data not shown). Figure 2A shows
a considerable enrichment of p53 in the high salt eluate Figure 1. Exonuclease Activity of Purified p53 Protein
of the antibody column over p53 in the lysate. Compari- Gel electrophoretic measurementsof exonuclease activity were car-
ried out with the 30-mer deoxyoligonucleotide 59-GACACTGGTCACson of the p53 elution profile with the profile of exo-
ACTTGGCTGCTTAGGAAT-39 (Foord et al., 1993). 39-Labeling wasnuclease activity in the corresponding fractions (Figure
performed with terminal transferase and [a-32P]ddATP (lanes 1–4)2B) demonstrates copurification of the exonuclease ac-
and 59-labeling with [g-32P]ATP and T4 polynucleotide kinase (lanestivity with the eluted p53, and Table 1 reveals an z5-fold
5–10) as described under Experimental Procedures. The exo-
enrichment of the specific exonuclease activity by im- nuclease activity was measured with z1 ng p53, here purified from
munoaffinity chromatography. The pooled p53 fractions baculovirus-infected Sf9 cells by affinity chromatography with im-
then were subjected tocolumn chromatography onhep- mobilized PAb421and subsequent elution with 1 M KCl. The reaction
products were analyzed on a 20% polyacrylamide gel containing 7arin-sepharose. The heparin column was developed
M urea. Lanes 1–3 show the production of ddAMP from the 39 endwith a salt gradient, ranging from 50 mM to 1 M KCl,
of the 39-labeled oligonucleotide after 5, 10, and 20 min incubationand individual fractions were analyzed by SDS–PAGE
at 378C; lane 4 displays the same experiment as shown in lane 3,followed by silver staining and for exonuclease activity
but in the presence of 5 mM GMP. Lanes 5–10 indicate product
as described above. p53 was eluted between 350 mM formation with the 59-labeled substrate after 0, 2, 4, 8, 15, and 30
and 450 mM KCl. SDS–PAGE analysis (Figure 2C) shows min incubation, respectively, at 378C.
that the p53 protein in the the p53-containing peak frac-
tions (lanes 5 and 6 in Figure 2C) was essentially pure
underscoring the tight association of this activity withas judged by silver staining. Figure 2D demonstrates
p53. Furthermore, purification of p53 by heparin-sepha-that the exonuclease activity eluted as a single peak
rose chromatography led to an additional, z4-fold in-from the heparin-sepharose column, and that its activity
crease in specific exonuclease activity of the pooledprofile closely followed the p53 elution profile, confirm-
fractions (Table 1), with the peak fractions in Figure 2Cing copurification of p53 with exonuclease activity. Over
(lanes 5 and 6) containing the highest specific exo-80% of the exonuclease activity applied to the heparin-
sepharose column was recovered (see Table 1), again nuclease activity (1126 U/mg).
Exonuclease Activity of p53
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optimal, and 80% and 40% of the optimal activity were
observed at 20 mM and 1 mM MgCl2, respectively (Table
2). Mn21 could replace Mg21, but its optimal concentra-
tion was 0.5 mM. The presence of 0.5 mM Mn21 gave
rise to only 10% of the maximal activity seen with 10
mM Mg21 (Table 2). On the other hand, Zn21, Ca21, and
Ni21 could not replaceMg21 or Mn21 (Table2). DNAdegra-
dation was sensitive to the addition of salt, where NaCl
exhibited half-maximal inhibition at z100 mM, and po-
tassium acetate was half-maximally inhibitory at 125
mM (Table 2). The pH optimum of the degradation reac-
tion was at around pH 8.5, with 80% and 70% residual
activity at pH values of 7.0 and 10.0, respectively (Table
2). Furthermore, the exonuclease was inhibited almost
completely by 5 mM GMP (Table 2), a concentration
that has been shown to inhibit effectively the 39-to-59
exonucleases of the mammalian DNA polymerases d
and e and E. coli DNA polymerase I (see: Bialek and
Grosse, 1993, and references therein). The p53 associ-
ated exonuclease activity was similarly inhibited by
dGMP, AMP, and dAMP, but not by nucleoside triphos-
phates (data not shown). Exonucleolytic activity could
be competed most effectively with the template · primer
combination poly(dA) · (dT)20, whereas the ssRNA
poly(rU) and the ssDNA poly(dT) were rather poor com-
petitors for exonucleolytic degradation (Figure 3).
The p53-Associated Exonuclease Exhibits
a 39-to-59 Polarity and Produces
Deoxynucleoside Monophosphates
The directionality of the p53 protein-associated exo-
nuclease was determined by using differently labeled
Figure 2. Copurification of p53 and Exonuclease Activity ssDNA substrates. With the 39-labeled substrate, the
p53 protein-associated exonuclease produced labeledMurine wt p53 protein was expressed in Sf cells infected with a wt
p53-recombinantbaculovirus. p53 was purified first by immunoaffin- nucleoside monophosphate only (Figure 1, lanes 1–3).
ity chromatography on a PAb421 column by high salt (1 M KCl) This finding is in accordance with our data showing
elution (A and B), followed by further purification of p53-containing that this exonuclease activity is inhibited by nucleoside
fractions on heparin-sepharose column (C and D). Fractions 3–14
monophosphates (see above) and argues for a 39-to-59(corresponding to lanes 1–12 in [A] and [B]) from high-salt eluate of
mechanism with the excision of one nucleotide afterthe PAb421 column were analyzed by SDS–PAGE and silver staining
another. In agreement with this view is the degradation(A), and for exonuclease activity by [3H]-filter retention assay, which
is displayedas columns of relative activity (B) as described in Experi- pattern of 59-labeled DNA substrates. Dependent on
mental Procedures. Fractions 4–9 (corresponding to lanes 2–7 in [A] the time of incubation a ladder of oligonucleotides was
and [B]) were pooled, loaded on a 2 ml heparin-sepharose column produced (Figure 1, lanes 6–10). Hence, the nuclease
and eluted with a salt gradient from 0.05 to 1 M KCl. A total of 30
removed dNMPs from the 39-end of the substrate, withfractions were collected; fractions 1, 5, 7–16, 20, and 25 were ana-
trinucleotides as the end product.lyzed by SDS–PAGE and silver staining (C). All fractions were tested
for exonuclease activity as described above (D). Exonuclease activ-
ity was seen only in fractions 8–15 (lanes 4–11). Monoclonal Antibodies against p53 Deplete
both the p53 Protein and the Associated
Exonuclease Activity from PreparationsBiochemical Properties of the p53-Associated
Exonuclease Activity of Purified p53 Protein
A 39-to-59 exonuclease activity was found in all prepara-The p53 protein-associated exonuclease activity was
dependent on the presence of Mg21, where 10 mM were tions of wt p53 protein, regardless of the starting source
Table 1. Purification of p53 Exonuclease Activity
Fraction Volume (ml) Total Protein (mg) Specific Activity (units/mg) Total Activity (units)
Crude extract 50 2075 48 100000
Immunoaffinity column, fractions 4–10 4 7.6 236 1800
Heparin–Sepharose column, fractions 8–15 6 1.7 882 1500
Immunoaffinity column fractions 4–10 correspond to lanes 2–9 in Figure 2A; Heparin–Sepharose column fractions 8–15 correspond to lanes
4–11 in Figure 2C. 1 Unit corresponds to degradation of 60 pM DNA per 10 min at 378C.
Cell
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Table 2. Characterization of the p53 Protein-Associated
Exonuclease Activity
Assay Conditions Degraded DNAa
Complete standard assay 1.0
pH 7.0 0.8
pH 8.5 1.0
pH 10.0 0.7
1 mM Mg21 0.4
10 mM Mg21 1.0
20 mM Mg21 0.8
0.5 mM Mn21 0.1 Figure 4. Immunodepletion of Exonuclease by p53-Specific Mono-
0.1–5 mM Ca21, Zn21, Ni21 0.0 clonal Antibodies
100 mM NaCl 0.5
About 1 mg each of the monoclonal anti-p53 antibodies PAb421,125 mM potassium acetate 0.5
PAb248, PAb1620, and the SV40 T antigen-directed antibody5 mM GMP , 0.05
PAb108, were added to 50 ng p53 protein, purified from Sf9 cells
The complete standard assay contained in a total reaction volume by Ni21-NTA affinity chromatography, in 100 ml of 50 mM Tris–acetate
of 20 ml 0.5 nM (2 ng) tetrameric p53 protein overexpressed and (pH 8.5), 100 mM NaCl, 1 mM DTT. Immunoprecipitated p53 protein
isolated from Sf9 cells, and 125 nM (tritiated 39 ends) poly (dA) • was removed by the addition of 50 ml protein A–Sepharose (Phar-
(dT)20 2 [3H]dT. A 100% loss of tritium label was achieved after 15 macia) and subsequent centrifugation. Exonuclease activity was
min incubation at 378C. This corresponds to a turnover number of measured in 2 ml of the supernatant with poly(dA)·(dT)20 2 [3H]dT
about 0.03 mol [3H]dTMP removed per second and mole of p53 as DNA substrate, as described under Experimental Procedures.
tetramer. Conditions deviating from the standard are indicated in “Control” indicates the loss of [3H] label in 1 ml of the assay mixture
the left-hand column. The right-hand column displays the relative without added protein A–Sepharose and without antibodies.
reaction rate in comparison to the optimized standard.
aRelative to standard assay.
Figure 5A shows that the p53 protein could be effectively
purified from the PAb421 column by 1 M KCl elution
(fractions 1–6), followed by alkaline elution at pH 12and the way of purification, providing evidence against
(fractions 7–16). Salt-eluted p53 starting from fractionan unspecific copurification of a contaminating exo-
4, and p53 recovered after alkaline elution, migrated asnuclease. This conclusion was further supported by
a single band on SDS–PAGE, and was >90% pure asdemonstrating that the monoclonal anti-p53 antibodies
judged by Coomassie blue staining. Comparison of thePAb421, PAb248, and PAb1620 completely depleted
elution profiles of the p53 protein and the profile ofboth p53 protein and the 39-to-59 exonuclease activity
exonuclease activity, as assayed by the filter retentionfrom the reaction mixture, while an unrelated mono-
assay (Figure 5B), revealed that the pattern of p53 pro-clonal antibody (PAb108) had no effect (Figure 4). Thus,
tein distribution and the pattern of exonuclease activitythis exonuclease activity either results from a very spe-
coincided, providing further evidence for a specific as-cific association of an exonuclease, present in eukary-
sociation of the exonuclease activity with p53. This con-otic as well as in bacterial cells, or it is intrinsic to the
clusion was also supported by the observation that, likep53 protein.
in the copurification experiment described in Figure 2,
the peaks of exonucleolytic activity closely paralleledThe Exonuclease Activity Copurifies with Wild-Type,
the peaks of p53 protein regardless of the purity of thebut not with Mutant p53 Protein
respective p53 protein fractions. This is exemplified byTo further demonstrate that the 39-to-59 exonuclease
comparing theexonuclease activity of the comparativelyactivity is specifically associated with p53, we purified
impure salt-eluted p53 fractions 1–3 to that of the rela-soluble human wt p53 protein, produced in bacteria, by
tively pure fractions 4–6. Although fractions 1–3 con-immunoaffinity chromatography on a PAb421-sepha-
tained considerably more contaminating proteins thanrose column as described in Experimental Procedures.
fractions 4–6, the exonuclease activity in all fractions
corresponded to the amount of p53 protein present in
each of these fractions. In a parallel experiment, in order
to further probe the specificity of this association and
to get an indication for the biological relevance of the
p53-associated exonuclease activity, we purified the hu-
man “hot-spot” 273His mutant p53 protein by the same
procedures as the corresponding wt p53 protein and
analyzed it for exonuclease activity as described above.
The 273His mutant was chosen because this DNA contact
mutant p53 (Cho et al., 1994) is one of the least defective
Figure 3. Substrate Requirements of the p53-Associated Exo- ones: the 273His mutant p53 protein still is able to assume
nuclease the wt p53 conformation (PAb16201, PAb2402, hsc702)
p53-associated exonuclease activity was measured with 1 ng p53 and to bind to wt p53 DNA-consensus elements when
protein, purified from Sf9 cells, and 125 nM (39 ends) poly(dA)·(dT)20 present in wt p53 hetero-oligomers (Rolley et al., 1995).
2 [3H]dT as substrate in a reaction volume of 20 ml as described
Thus the defect of this mutant in sequence-specific DNAin Experimental Procedures. Poly(dA)·(dT)20, poly(rU), and poly(dT)
binding does not necessarily have a discernable effectserved as competitors at concentrations of 40 ng (left columns),
400 ng (middle columns), and 4 mg (right columns), respectively. on tertiary structure (Friend, 1994; Ory et al., 1994). One
Exonuclease Activity of p53
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Figure 6. Exonuclease Activity of Thermo-Sensitive tsp53val135
Protein
Exonuclease activity was measured with a 59-labeled oligonucleo-
tide and analyzed by 20% polyacrylamide gel electrophoresis under
nondenaturing conditions (Hupp et al., 1992). Lane 1 contained only
the oligonucleotide; lane 2 displays reaction products after 20 min
incubation at 208C with 2.5 ng ts p53val135 isolated from cells grown
at 328C (wild-type form); lane 3 shows reaction products after 20
min incubation at 208C with 5 ng ts p53val135 isolated from cells grown
at 388C (mutant form).
Figure 5. Exonuclease Activity of Immunoaffinity-Purified Wild-
Type and 273His Mutant p53
Soluble bacterially expressed human wt p53 (A and B) and 273His form of p53, we next purified the temperature-sensitive
mutant p53 (C and D) were immunopurified and tested for exo- mouse tsp53val135 from rat clone 6 cells. When clone 6
nuclease activity. (A) and (C) show the purification of wt p53 (A) or cells are grown at 388C, the tsp53 protein predominantly
mutant p53 (C), as monitored by SDS–PAGE analysis of proteins in
assumes a mutant phenotype, whereas in cells grownfractions eluted from the PAb421 column with 1 M KCl (fractions
at 328C this protein displays wild-type properties (Mi-1–6), followed by alkaline elution at pH 12 (fractions7–16; see Experi-
chalovitz et al., 1990). tsp53 from clone 6 cells grownmental Procedures). Aliquots from each fraction were acid precipi-
tated and analyzed by SDS–PAGE. A sample (2.5 ml) of each fraction either at 388C or at 328C was purified by immunoaffinity
was tested for exonuclease activity by [3H]-filter retention assay; chromatography and tested for exonuclease activity.
results displayed as columns of relative exonuclease activity as “Wild-type” tsp53 protein isolated from clone 6 cells
described in Experimental Procedures ([B], wt p53; [D] 273His mu-
kept at 328C had a prominent exonuclease activity whentant p53).
incubated with the single-stranded 30-mer oligonucleo-
tide (Figure 6, lane 2). In contrast, mutant tsp53val135 pro-
tein recovered from clone 6 cells kept at 388C displayedthereforecan assume that this mutant protein most likely
is similar to wt p53 in its protein binding properties. only marginal exonuclease activity when compared to
the tsp53 protein in its wild-type form (Figure 6, lane 3).Figure 5C shows that the 273His mutant p53 protein was
recovered in a higher yield as the wt p53 protein. How- However, themutant formof the tsp53 protein still bound
ssDNA, as judged from the shift of most of the inputever, in contrast with the wt p53 protein, the mutant
protein was devoid of detectable exonuclease activity. DNA to the top of the gel in the presence of the mutant
form of tsp53 (Figure 6, lane 3).As this human 273His mutant p53 protein was expressed
from the same vector, produced in the same bacterial
strain, and purified the same way as the corresponding SDS-PAGE-Purified and Renatured p53
Protein Retains Exonuclease Activitywt p53 protein, this finding strongly supports the notion
of a highly specific and biologically relevant association The data presented so far are compatible with either a
very specific association of an exonuclease copurifyingof an exonucleolytic activity with wt p53. We also have
analyzed the 175His mutant of p53, which is a structural with p53 in its wild-type form from bacterial to mamma-
lian cells, or, alternatively, with wt p53 exhibiting anmutant (Cho et al., 1994), and therefore is in the mutant
conformation. As expected, we found it to be negative intrinsic exonuclease activity. To rigorously discriminate
between these alternatives, we wanted to exclude thefor exonuclease activity.
To further substantiate our claim that an exonucleo- possibility of any noncovalent protein–protein interac-
tion during purification. Therefore, we solubilized mouselytic activity is specifically associated with the wild-type
Cell
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Figure 8. UV Photocross-Linking of GMP to p53 Protein
UV-crosslinked p53 (see Experimental Procedures) and a molecular
weight marker were separated by SDS–PAGE. The gel was stained
with Coomassie, dried, and analyzed by autoradiography to an X-ray
film. The autoradiograph shown in lane 3 corresponds to the Coo-
massie stain shown in lane 2. Lane 1 contained b-galactosidase
(116 kDa), phosphorylase b (96 kDa), bovine serum albumin (68 kDa),
and ovalbumin (43 kDa) as molecular weight markers.
proteins such as bovine serum albumin,yielded negative
results (data not shown).
UV Photocross-Linking of GMP to p53 Protein
To provide additional independent evidence for an in-
trinsic exonuclease activity of the p53 protein, we further
Figure 7. Exonuclease Activity Associated with p53 Protein after analyzed the inhibitory effect of GMP on the exonucleo-
SDS–PAGE and In Situ Renaturation
lytic activity of p53 (Figure 1, lane 4; Table 2). If the
Bacterially expressed murine p53 protein was solubilized from inclu-
exonuclease activity were intrinsic to the p53 protein,sion bodies in the presence of 6 M guanidinium hydrochloride. The
then its inhibition by GMP would have to be due to GMPsolubilized protein was further purified by nickel-NTA chromatogra-
binding to a nucleoside monophosphate binding site,phy. Guanidinium was removed by subsequent dialysis against
buffer containing decreasing concentrations of urea. After this step, serving as “exit site” for exonucleolytically released
the p53 protein was >95% pure but displayed <1% of the exo- dNMPs. Such a hypothetical site might be detected by
nuclease activity seen with purified p53 protein from Sf9 cells. De- photocross-linking GMP to highly purified p53 in solu-
picted in (A) is the experimental design for measuring exonuclease
tion (see Experimental Procedures). This indeed was theactivity of guanidinium-solubilized bacterial p53 after column purifi-
case, as a rather specific and efficient cross-linking ofcation, subsequent purification on an SDS gel, electrotransfer onto
the radioactively labeled GMP to the p53 protein wasnitrocellulose, and in situ protein renaturation. Displayed in (B) is
the time-dependent exonuclease activity under the p53 band (lanes observed (Figure 8, lane 3). No other hypothetically co-
1–6). Lanes 7 and 8 show a control, where a piece of nitrocellulose purifying protein could be cross-linked to [32P]GMP, fur-
filter was taken immediately upward of the p53 band. ther supporting our conclusion that the exonuclease
activity associated with purified p53 is intrinsic to the
p53 protein.wt p53 from bacterial inclusion bodies in the presence
of 6 M guanidinium chloride, purified it by nickel-chelate
chromatography, and renatured it by using a refolding The p53 Exonuclease Activity Maps to the Core
Domain of the p53 Moleculeprotocol in the presence of decreasing concentrations
of urea (see Experimental Procedures). The highly puri- The p53 molecule can be functionally and structurally
divided into three domains, separated by hinge regionsfied p53 protein was loaded onto an SDS polyacrylamide
gel and separated from possibly still-copurifying con- (Bargonetti et al., 1993; Pavletich et al., 1993; Wang et
al., 1993): the N-terminal transactivator domain (aminotaminants by gel electrophoresis. Then, we transferred
the p53 protein onto a nitrocellulose membrane, rena- acids 1–42; Lin et al., 1994); the core domain (amino
acids 120–290), which is the sequence-specific bindingtured it on the membrane, and tested for exonuclease
activity. Even after this extremely stringent purification domain of p53 (Bargonetti, et al., 1993; El-Deiry et al.,
1992); and the C-terminus (amino acids 311–390), whichprotocol (Figure 7A), the excised band that contained
p53 protein showed a time-dependent 39-to-59 exo- contains the p53 oligomerization domain (Stu¨rzbecher
et al., 1992), the nuclear localization signals (Shaulskynucleaseactivity (Figure 7B). In contrast, such an activity
was not seen with nitrocellulose pieces obtained imme- et al., 1990), several regulatory phosphorylation sites
(Hupp and Lane, 1994; Meek, 1994), and a non-se-diately above or below the position of the p53 band
(Figure 7B). Further controls, including similar analyses quence-specific DNA/RNA binding domain (Foord et al.,
1991; Wang et al., 1993; Mosner et al., 1995). Althoughperformed with the 273His mutant p53 and with unrelated
Exonuclease Activity of p53
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localizing the p53 exonucleolytic activity to the central
DNA binding domain of p53. As this domain is the main
target for mutational inactivation of p53’s tumor sup-
pressor function, this finding suggests that mutations
in the core domain, like in 273His mutant p53, may also
inactivate p53’s exonuclease activity. Our finding, that
the purified 24 kDa core domain of p53 displayed exo-
nuclease activity, also eliminates the remote possibility
that a bacterial exonuclease, comigrating with the p53
protein in SDS–PAGE, might be responsible for the exo-
nucleolytic activity observed with full-length p53, shown
in Figure 7B.
Discussion
The present view of the molecular action of the tumor
suppressor p53 implies a function as a cell cycle regula-
tor in response to DNA damage (reviewed in Cox and
Lane, 1995). In this study we provide stringent evidence,
derived from several independent experimental ap-
proaches, that wild-type p53 protein displays an intrinsic
exonuclease activity. Mammalian cells contain a variety
of different exonucleases with functions in DNA replica-
tion, DNA recombination, and DNA repair (see e.g., Korn-
berg and Baker, 1991; Linn et al., 1993). Thus, the exo-
nuclease activity associated with p53 might act in all
these processes.
The exonuclease activity of p53 could be mapped to
the central core of the p53 molecule, which is the target
for most of the missense mutations inactivating the tu-
mor suppressor function of p53, like in the human hot-
spot 273His mutant of p53, which also lacked exo-
nuclease activity. So far, the most prominent feature of
Figure 9. The Core Domain of the p53 Protein Displays Exonuclease the wild-type p53 core domain is its ability to bind to
Activity. p53 DNA consensus elements in a sequence-specific
Bacterially expressed protein fragments of the murine p53 protein manner. Sequence-specific DNA binding of the core do-
(the core domain consisting of amino acids 80–290 and a C-terminal main seems to be regulated by the p53 C-terminus and
fragment comprising the amino acids 290–390) were treated as
can be activated by a variety of posttranslational modifi-shown in (A). Displayed in (B) is the time dependent exonuclease
cations (Hupp and Lane, 1994) and/or by recognition ofactivity under the band corresponding to the core domain of p53
DNA bulges resulting from DNA deletion/insertion mis-(lanes 1–4). No exonuclease activity could be detected either under
the band of the C-terminal fragment (lane 5) or the control piece matches (Lee et al., 1995). In addition, the p53 core
corresponding to a protein size of 53 kDa (lane 6). The heterogeneity domain has been shown to bind nonspecifically to inter-
of the DNA used in this experiment was due to incomplete purifica- nal regions of single-stranded DNA (Bakalkin et al.,
tion of the chemically synthesized oligonucleotide (lane 7). Note
1994). The 39-to-59 exonuclease activity described forthat a nitrocellulose piece cut out from the 53 kDa region of the
the core domain in this study defines yet another func-nitrocellulose blot above the 24 kDa p53 core fragment (control in
tion for this domain. Such multiple functions might be[A] and [B]) did not exhibit exonuclease activity, further excluding
the possibility that an exogenous 53 kDa exonuclease copurifies considered unusual for a single protein domain. How-
with p53. ever, one has to bear in mind that the DNA binding
domain of p53, as defined by X-ray crystallography,
represents a hitherto unknown binding domain for the
our finding that the 273His mutant was devoid of exo- sequence-specific interaction of DNA binding proteins
nucleolytic activity (Figure 5) already suggested an with DNA, marked by the compaction of several individ-
involvement of the central core domain in this activity, ual DNA binding elements (Cho et al., 1994). Of particular
this did not unequivocally exclude the possibility that interest in this regard is the recently demonstrated simi-
the p53-intrinsic exonuclease activity was mediated by larity between the DNA binding domain of p53 and the
the p53 C-terminal nonspecific DNA binding domain. catalytic domain of the major apurinic/apyrimidinic (AP)
To discriminate between these possibilities, bacterially repair endonuclease in E. coli, exonuclease III (Mol et
expressed p53 fragments comprising the core domain al., 1995). The catalytic domain in this multifunctional
(amino acids 80–290) or the C-terminus of p53 (amino enzyme is made up by an ab-sandwich scaffold encom-
acids 290–390) (Mu¨ller et al., 1996) were purified by the passing a single divalent metal cation site. This ab-
denaturation/renaturation protocol as described above sandwich scaffold positions the structural elements,
and analyzed for exonuclease activity (Figure 9). Figure including a protruding basic helix, required for DNA in-
9B shows that only the p53 core domain, but not the teraction. A similar ab-sandwich scaffold has been
found for the p53-DNA complex (Cho et al., 1994).p53 C-terminus exhibited exonuclease activity, thereby
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p53 protein levels are rapidly induced after g-irradia- synthesis might also be performed by the PCNA-inde-
tion of living cells. This type of radiation preferentially pendent and proofreader-free DNA polymerases b and/
induces dsDNA breaks (Kastan et al., 1992; Nelson and or a. Thus, the increase of p53 protein levels after dam-
Kastan, 1994), which subsequently are repaired by re- age induction might not only shut off PCNA-dependent
combination processes (Szostak et al., 1983). Double- DNA replication, but might also increase the accuracy
strand break repair is thought to require DNA helicases, of DNA synthesis performed by the more error-prone
such as the Ku autoantigen (Suwa et al., 1994; Tuteja DNA polymerases b and a due to the active contribution
et al., 1994), and exonucleases. Hence, the exonuclease of a 39-to-59 proofreading exonuclease. Regardless in
activity of p53 might be directly involved in repair pro- which of these proposed functions the intrinsic 39-to-59
cesses such as dsDNA break repair. Another type of exonuclease would participate, the demonstration of
error avoidance mechanism requiring exonuclease ac- this catalytic activity for p53 should expand the role of
tivities is the so-called postreplicative mismatch repair p53 from a protein acting primarily upon exogeneously
pathway. In bacteria this system invokes the coordi- inflicted DNA damage to an active participant in a variety
nated action of the MutSLH damage recognition/endo- of DNA repair processes, including replication-associ-
nuclease complex along with the UvrD helicase, DNA ated DNA repair.
polymerase III, DNA ligase, single-strand DNA binding
protein, and any one of the exonucleases ExoI (39-to-59
Experimental Proceduresexo), ExoVII (39-to-59 and 59-to-39 exo) or RecJ (59-to-39
exo) (Modrich, 1987; Modrich, 1989). An involvement of Bacteria and Cells
p53 protein’s exonuclease in the postreplicative mis- Human wt p53 cDNA, human 273His mutant p53, and human 175His
match repair pathway would be of particular interest mutant p53 cDNA (mutant cDNAs were provided by H.-W. Stu¨rz-
because this would link one of the enzymological func- becher, Heinrich-Pette-Institute, Hamburg, Germany) were inserted
into the pET3A plasmid, and expressed in BL21(DE3) bacteriations of p53, i.e. its exonuclease activity, to the tumor
(Studier et al., 1990). About 50% of the overexpressed wt p53 proteinsuppressor function of the mammalian MutSLH homo-
and about 10% of the overexpressed mutant p53 were soluble.logs hMSH2, hMLH1, hPMS1, and hPMS2. Functional
Furthermore, a murine wt p53 cDNA, containing sequence informa-
loss of either of these proteins leads to an increased tion for six histidine residues (His6) at the N-terminus, was inserted
incidence of colon carcinomas (for reviews, see Radman into the pH6EX3 vector and expressed in DH5a bacteria, but deliv-
and Wagner, 1993; Bodmer et al., 1994; Modrich, 1994). ered p53 protein as insoluble inclusion bodies. A recombinant bacu-
lovirus that overexpressed the wild-type form of murine p53 proteinFurthermore, mutations in any of these genes display a
with coding information for a His6 tag at the N-terminus (Wang etgeneralized increase in spontaneous mutation rates, a
al., 1993) was provided by P. Tegtmeyer (SUNY, Stony Brook). Clonereplication error–positive (RER1) phenotype, and a resis-
6 cells, i.e. rat embryo cells transformed with p53val135 and activatedtance to alkylating agents (Leach et al., 1993; Parsons
ras oncogene (Michalovitz et al., 1990), were provided by M. Oren
et al., 1993; Bhattacharyya et al., 1994). In this respect, (Weizmann Institute, Rehovot, Israel).
it is intriguing that a relative resistance to alkylating
agents was also observed with p53-deficient animals
Preparation of Crude Cell Lysates(Harvey et al., 1993). Furthermore, there is also some
p53 from Recombinant Baculoviruses
evidence that, like wild-type p53 protein itself (Wies- About 109 Sf9 insect cells were infected with the corresponding
mu¨ller et al., 1996), an intact mammalian MutSHL system recombinant baculovirus (Wang et al., 1993). Cells were harvested,
displays an “anti-recombinogenic”effect (Fisheland Ko- 48 hr after infection, with a rubber policeman and lysed by the
addition of 50 ml ice-cold lysis buffer (20 mM Tris [pH 8.0], 2 mMlodner, 1995). In line with the possibility of a direct
EGTA [pH 8.0], 0.5% Lubrol, 500 mM NaCl, 10 mM dithiothreitolinvolvement of p53 in mismatch repair is the recent dem-
[DTT], 2 mM phenylmethylsulfonyl fluoride [PMSF], 5 mM Na2S2O5,onstration that wt p53 can “sense” DNA mismatch le-
50 mg/ml Leupeptin, 1% [v/v] Trasylol [Bayer, Leverkusen, FRG]).sions by tightly binding to DNA-containing insertion/
Bacterially Expressed p53
deletion mismatches (Lee et al., 1995). Human wt p53 protein and 273His or 175His mutant p53 were prepared
Last but not least, the biochemical similarity between from the soluble fraction of an E. coli overexpressing strain. Bacterial
proofreading exonucleases of various DNA polymerases cells were pelleted and lysed by addition of 50 ml ice-cold lysis
buffer as described above.and p53’s exonuclease provokes the tempting specula-
p53 from Clone 6 Cellstion that p53 might act as external proofreader for errors
About 109 cells were grown at 328C as well as at 388C, harvestedproduced by some of the cellular DNA polymerases. In
by rubber policeman, washed and lysed by addition of 50 ml ice-eukaryotes, two of the replicative DNA polymerases,
cold lysis buffer as described above.
namely the PCNA-dependent polymerases d and e, con-
tain an intrinsic 39-to-59 exonuclease activity that has
Immunoaffinity Chromatographybeen shown to act as proofreader for errors produced
Crude lysate was centrifuged at 200,000 g for 1 hr to remove cellular
by either enzyme. In contrast, two further polymerases, debris. The clarified extract was diluted 5-fold with 20 mM Tris (pH
DNA polymerases a and b, do not possess such an 8.0), 2 mM EGTA (pH 8.0), 0.5% Lubrol, 2 mM PMSF, 5 mM Na2S2O5,
intrinsic proofreading function (Wang, 1991). However, 50 mg/ml Leupeptin, 1% (v/v) Trasylol (Bayer, Leverkusen, FRG),
DNA polymerase a is certainly involved in nuclear DNA and centrifuged for 20 min at 20,000 g to remove precipitated pro-
teins. The cleared extract was loaded onto a 1 ml column containingreplication, whereas DNA polymerase b has been as-
1 mg purified PAb421 coupled to CNBr-activated Sepharose 4B-signed to DNA repair processes (Wang, 1991). When
CL (Pharmacia) and washed with 200 ml buffer A (30 mM potassiumDNA damage has occurred, there is an apparent shutoff
phosphate [pH 8.0], 50 mM KCl, 1 mM EDTA, 2 mM DTT).
of PCNA-dependent DNA replication (Flores-Rozas et Salt Elution
al., 1994; Waga et al., 1994). Although PCNA-dependent The column was eluted with 15 ml 1 M KCl in buffer A, and 1 ml
DNA-repair synthesis still seems to continue under con- fractions were collected. This step eluted z25% of the loaded p53
protein with a purity of >85% as judged from SDS–PAGE.ditions of p21CIP1/WAF1 induction (Li et al., 1994), DNArepair
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Alkaline Elution (Stratagene); incubation was for 30 min at 308C. After heat-inactiva-
tion for 10 min at 658C, 0.2 mM poly(dA) was added and the reactionThe remaining p53 protein was eluted with 10 ml buffer B (100 mM
mixture was allowed to cool down slowly to room temperature. Thepotassium phosphate [pH 12.0], 1 M KCl, 1 mM EDTA, 2 mM DTT,
reaction mixture was passed through a 1 ml spin column filled withand 20% glycerol) and immediately neutralized by the addition of
Sephadex G-50 (Pharmacia) that was equilibrated with 50 mM Tris–an appropriate amount of KH2PO4 (Nasheuer and Grosse, 1987).
acetate [pH 7.3], 1 mM EDTA. This step removed unincorporatedp53-containing fractions were concentrated by dialysis against solid
dNTPs and the reaction buffer. The labeled product was pipettedpolyethylene glycol 40,000 (Merck, Darmstadt, Germany) to a con-
onto the hydrophilic side of a microdialysis membrane (Type VS,centration of about 50–100 mg/ml. The concentrated fraction could
pore size 0.025 mm, Millipore, Eschborn, FRG) that swam on 20 mlbe stored for about 3 weeks at 48C without considerable loss of
10 mM Tris–HCl [pH 8.0], 0.1 mM EDTA. Dialysis was carried outexonuclease activity.
for at least 2 hr at room temperature. After dialysis, the specific
activity was typically 160 cpm/fmol.
Heparin-Sepharose Column Chromatography Preparation of 59-Labeled Oligonucleotides
p53 was partially purified by immunoaffinity chromatography and Oligonucleotides were 59-labeled with [g-32P]ATP by using T4 poly-
high salt elution as described above. p53-containing fractions were nucleotide kinase according to a standard procedure (Sambrook et
pooled, diluted to a salt content of 50 mM KCl, and loaded on a 2 al., 1989). Unincorporated radioactivity was removed by separation
ml heparin-sepharose column. After washing with 25 ml buffer A over a 20% polyacrylamide gel; the labeled oligonucleotides were
(30 mM potassium phosphate [pH 8.0], 50 mM KCl, 1 mM EDTA, 2 detected by an autoradiography. Corresponding gel slices were
mM DTT), proteins were eluted in a total volume of 30 ml by a salt cut out and extracted with Tris–EDTA (pH 8.0) overnight at room
gradient from 0.05–1 M KCl in buffer A. temperature.
Measurement of 39-to-59 Exonuclease Activity
by Filter Binding AssaysAffinity Purification of Histidine-Tagged Protein
The 39-to-59 exonuclease activity was assayed by measuring theWhen histidine-tagged p53 protein was overexpressed, the crude
loss of 39-labeled nucleotides after incubation with enzyme. Thecellular extract was passed over a 1 ml nickel-NTA column (Qiagen)
reaction mixture (20 ml) contained 50 mM Tris–acetate (pH 8.5), 10(Wang et al., 1993). The column was washed with 50 ml of buffer C
mM magnesium acetate, 1 mM DTT, 0.1 mg/ml bovine serum albu-(50 mM imidazole [pH 7.5], 100 mM Tris [pH 7.0], 150 mM NaCl, 1
min, and 125 nM (tritiated 39 ends) of labeled poly(dA) · (dT)20-[3H]dTmM PMSF, 0.5% Lubrol) and eluted with buffer D (250 mM imidazole
(z10,000 cpm). The reaction was started by the addition of 1–2 ng[pH 7.5], 100 mM Tris [pH 7.0], 150 mM NaCl, 1 mM PMSF, 0.5%
p53 and performed for 15 min at 378C. The exonuclease activity ofLubrol). Protein prepared in this manner was exonuclease proficient
T4 DNA polymerase (donated to us by L. Reha-Krantz, Universityand >90% pure. Concentration and storage were as described
of Alberta, Edmonton, Canada) served as a positive control. Theabove.
mixture was spotted onto DE81 filters (Whatman, Maidstone, UK),
the filters were washed (2 ml, five times) with 0.5 M (NH4)HCO3 and
Purification of p53 by Affinity Chromatography, then dried under infrared light. Radioactivity that remained on the
SDS–PAGE, and Renaturation filters was measured by liquid scintillation counting.
Insoluble murine p53 was collected by centrifugation of bacterial Measurement of Exonuclease Activity by Gel Electrophoresis
crude extracts and solubilized in 6 M guanidinium chloride. Solubi- Gel electrophoretic measurements of exonuclease activity were per-
lized p53 was purified in the presence of 6 M guanidinium hydrochlo- formed with 1–2 ng of the 30-mer deoxyoligonucleotide 59-GACACT
ride by chromatography on a nickel-chelate column, essentially as GGTCACACTTGGCTGCTTAGGAAT-39 (Foord et al., 1993). The oli-
described above. Guanidinium was removed by subsequent dialysis gonucleotide was chemically synthesized by using the phos-
against buffers containing decreasing concentrations of urea (1 M, phoroamidite method and purified by reversed phase HPLC and
0.8 M, 0.5 M, 0.1 M, and no urea). Guanidinium hydrochloride– subsequent gel electrophoresis. 59-labeling with [g-32P]ATP and
solubilized p53 protein was to >95% pure but after renaturation T4 polynucleotide kinase was according to a standard proce-
typically displayed <1% of the exonuclease activity observed with dure. 39-labeling was performed with terminal transferase and
purified soluble protein from the other sources. This protein was [a-32P]ddATP (Amersham) according to the instructions of the manu-
facturer of the 39-labelingkit (Boehringer). In both cases, the reactionloaded onto a 10% SDS–PAGE (Laemmli, 1970) and separated by
products were analyzed on a 20% polyacrylamide gel containingelectrophoresis at 10 V/cm at room temperature. The protein was
7 M urea.transferred electrophoretically onto a nitrocellulose membrane (Hy-
bond C super, Amersham). Protein standards, including a p53 stan-
UV Cross-Linking of GMP to the p53 Proteindard, were visualized with amido black. Nitrocellulose slices con-
A total of 1 mg of p53 protein, overexpressed from Sf9 cells, wastaining unstained p53 as well as control slices taken from the
incubated with 50 mCi of [32P]GMP (3000 Ci/mmol; Hartmann Analytikneighborhood of the p53 band (see Figures 7A and 7B) were excised
GmbH, Braunschweig, FRG) in 25 mM Tris–HCl (pH 8.5), 10 mMfrom the membrane at their corresponding positions. Renaturation
MgCl2, 75 mM potassium acetate. Samples were irradiated with 0.3of the protein was performed by subsequent incubation in 50%
J/cm2 at 254 nm (Nasheuer and Grosse, 1988). UV-crosslinked p53isopropanol as follows: for 30 min in renaturation buffer 1 (50 mM
and a molecular weight marker were separated by SDS–PAGE. TheNaCl, 10 mM Tris–HCl [pH 7.0], 2 mM EDTA, 1 mM DTT, 4 M urea,
gel was stained with Coomassie, dried, and analyzed by autoradiog-1% Triton X-100), two times for 30 min each; in renaturation buffer
raphy.1 without Triton X-100, two times for 30 min each; and finally for 30
min in renaturation buffer 2 (50 mM NaCl, 10 mM Tris–HCl [pH 7.0],
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